PTC THERAPEUTICS, INC.
PTCTPharmaceutical Preparations · SIC 2834 · CIK 0001070081
Revenue FY2025
$1.73B
Net Income
$0.68B
EPS (Basic)
$8.58
Net Margin
39.4%
ROE
-332.5%
Total Equity
$(0.21B)
Shares Out
83M
PTC THERAPEUTICS, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
$94.4M
0.3%
NEW
Renaissance Technologies
Renaissance Technologies
$59.0M
0.1%
+35.7%
OrbiMed Advisors
OrbiMed Advisors
$4.0M
0.0%
—
Polen Capital Management
Polen
$2.0M
0.0%
NEW
WCM Investment Management
WCM Investment Management
$7.7M
0.0%
(0.9%)
Royce & Associates
Royce & Associates
$0.8M
0.0%
(89.7%)
Insider Transactions
Reading stored insider transactions…